Technology Entrepreneurship @ Chuck Eesley
Stanford
Manu Sharma - Japan2013.09.22
Start-up in Focus
2013.09.22 Manu Sharma - Japan
BioconBiopharma Enterprise focussed on
INNOVATION to deliver
‘AFFORDABLEHEALTHCARE’
Start-up in Focus
2013.09.22 Manu Sharma - Japan
BioconIdea behind this Start-up as stated by Founder
‘FOOLISH COURAGE’ to pioneer in a novel field of
‘BIOTECHNOLOGY’
Biocon – What is it?
2013.09.22 Manu Sharma - JapanSyngene and Clinigene are the subsidiaries of Biocon
Biocon – The Story so far?
2013.09.22 Manu Sharma - Japan
Biocon – Success?
2013.09.22 Manu Sharma - Japan
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
1Seizing
‘OPPORTUNITY’ ,right one at the right time!!!
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
1 ‘OPPORTUNITY’was TIMELYwas SOLVABLEwas IMPORTANTwas PROFITABLEwas in CONTEXT
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
2Having
‘CAPABILITY’ Knowledge, Skill and Education!!!
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
2 Founder had‘CAPABILTY’by EDUCATIONby SKILLby EXPERIENCEby ATTITUDEby VISION
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
3Having
‘VISION’ backed by robust Business Model!!!
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
3 Aligned ‘VISION’with CAPABILITIESwith SUSTAINANCEwith MARKET NEEDwith BUSi.PLAN
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
4Applying
‘INNOVATION’ Consistently with proper Methodologyl!!!
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
4 Applying ‘INNOVATION’
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
5Purpose to be
‘HUMANITARIAN’ Striving for betterment of People and Environment!!!
Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
5 Purpose‘HUMANITARIAN’being LOCAL yet GLOBALBiocon is committed to reduce therapy costs of chronic diseases like DIABETES, CANCER and AUTOIMMUNE diseases by leveraging India's cost advantage to deliver affordable healthcare solutions to patients, partners and healthcare systems across the GLOBE.
References
2013.09.22 Manu Sharma - Japan
1. http://en.wikipedia.org/wiki/Kiran_Mazumdar-Shaw2. www.biocon.com3. Investors’ Presentation “Biocon_IRPrstn_July2013”4. Technology Ventures – from Idea to Enterprise by
Thomas H. Byers Stanford University, Richard C. Dorf University of California, Davis Andrew J. Nelson, University of Oregon
Top Related